Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection

Sorafenib (Nexabar, Bayer, Berlin, Germany), one of multikinase inhibitors, can infrequently downstage advanced hepatocellular carcinoma (HCC). There are some reports that sorafenib in combination with other modalities, such as transcatheter arterial chemoembolization (TACE) or radiation therapy, co...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Int Surg
المؤلفون الرئيسيون: Nakamura, Kenichi, Beppu, Toru, Hayashi, Hiromitsu, Okabe, Hirohisa, Imai, Kastunori, Nitta, Hidetoshi, Chikamoto, Akira, Ishiko, Takatoshi, Sasaki, Masato, Baba, Hideo
التنسيق: Artigo
اللغة:Inglês
منشور في: The International College of Surgeons, World Federation of General Surgeons and Surgical Specialists, Inc. 2015
الموضوعات:
Hepatobiliary & Pancreatic Surgery
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452982/
https://ncbi.nlm.nih.gov/pubmed/26011214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9738/INTSURG-D-14-00133.1
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة